INSMED Inc — Director's Dealing 2020

Jan 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2020-01-03

Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-03	Common Stock	A	10526	—	Acquired	36531	Direct
2020-01-03	Common Stock	F	979	$23.75	Disposed	35552	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-03	Stock Option (right to buy)	$23.75	A	56520	Acquired	2030-01-03	Common Stock (56520)	Direct

Footnotes

F1: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3: Includes 1,655 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

F4: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

F5: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.